SpaceX Regains $150 IPO Open Price as Defense Dept. Confirms Space-Based Weapons
SpaceX (SPCX) shares rose 5.1% to $151 after the Pentagon confirmed on-orbit space weapons tied to its $6B+ Starshield contracts. Q2 revenue beat estimates at $7.81B, with Starlink subscribers doubling to 12M and enterprise revenue up 108% YoY. The stock is up 44% from its post-IPO low but still 33% below its intraday high.
How this was made

The 30-second read
Why it matters
The confirmation translates policy intent into tangible revenue potential for SpaceX, reinforcing its defense market positioning.
Market read
Fresh defense policy news drives a notable price move in SPCX and may lift related aerospace stocks.
What to watch
Potential regulatory scrutiny of on‑orbit weapons could temper long‑term upside.
Background
SpaceX's Starshield business supports U.S. Space Force contracts; the Pentagon's Golden Dome line item totals $17.9B.
Ticker impact
Pentagon confirmed on‑orbit space weapons tied to SpaceX's $6B+ Starshield contracts, driving a 5.1% price rise.
Expect continued upside pressure as investors price in additional defense allocations.
Fresh policy news directly links to SpaceX's core revenue stream and triggers a notable intraday move.
Market effects
Defense and aerospace stocks may benefit from the confirmed Golden Dome spend.
U.S. defense contractors could see heightened investor interest.
International satellite and security firms may experience spillover effects.
Counterpoint
If the Pentagon's budget faces congressional hurdles, the rally could be short‑lived.
Key entities
- companySpaceX
U.S. aerospace firm with Starshield defense contracts.
- governmentPentagon
U.S. Department of Defense confirming on‑orbit weapons program.




